A randomized phase II study of preoperative Herceptin [trastuzumab]/Navelbine [vinorelbine] versus Taxotere [docetaxel]/Carboplatin/Herceptin in early stage, HER-2 positive breast cancer.
Phase of Trial: Phase II
Latest Information Update: 03 Feb 2016
At a glance
- Drugs Docetaxel (Primary) ; Trastuzumab (Primary) ; Vinorelbine (Primary) ; Carboplatin
- Indications Early breast cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 03 Feb 2016 Pooled results published in the Clinical cancer research: an official journal of the American Association for Cancer Research
- 04 Jun 2010 Results presented at the 46th Annual Meeting of the American Society of Clinical Oncology.